Early intestinal barrier changes in A53T transgenic Parkinson’s disease mice
Myat Noe Han, Olivia Artaiz, Matthew C. Rowe, David I. Finkelstein, Shanti Diwakarla, Rachel M. McQuade

TL;DR
This study shows that gut barrier issues appear before brain changes in a mouse model of Parkinson’s disease, suggesting the gut could be an early target for treatment.
Contribution
The study identifies early intestinal barrier dysfunction in A53T transgenic mice before CNS pathology, offering new insights into Parkinson’s disease progression.
Findings
A53T mice showed increased intestinal permeability at 12 and 36 weeks.
Early reductions in Claudin-1 and altered mucin expression were observed in the ileum and colon.
Gut dysfunction occurred before central nervous system changes in the PD mouse model.
Abstract
Gut dysfunction commonly precedes motor symptoms in Parkinson’s disease (PD), but the mechanistic sequence of gut versus brain pathology remains unclear. This work aimed to define the timing of intestinal barrier dysfunction relative to central nervous system (CNS) changes in the A53T α-synuclein transgenic mouse model of PD. Functional and molecular assessments of the gastrointestinal tract (ileum and colon) were conducted at 12 and 36 weeks. We measured in vivo and ex vivo intestinal permeability, nutrient absorption, histomorphology, goblet cell density, and expression of MUC2 and Claudin-1. Inflammatory markers (CRP, TNF-α, CD45) were quantified in plasma and gut tissues. A53T mice exhibited increased intestinal permeability at 12 and 36 weeks, with transiently elevated ex vivo transepithelial electrical resistance (TER) at 12 weeks. Nutrient absorption remained intact.…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsParkinson's Disease Mechanisms and Treatments · Barrier Structure and Function Studies · Dysphagia Assessment and Management
